Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 3/20 | 0.52 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.52 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3464413 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL9326029 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2819570 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2387925 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL3463001 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL16294494 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL16294105 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL3464839 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL3464415 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2390985 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8884041-B2 | Method for synthesizing an omega-amino acid or ester from a monounsaturated fatty acid or ester | ARKEMA FRANCE (FR) | 2014-11-11 | — | — | US | disclosed |
| US-20140187808-A1 | METHOD FOR SYNTHESIZING AN OMEGA-AMINO ACID OR ESTER FROM A MONOUNSATURATED FATTY ACID OR ESTER | ARKEMA FRANCE (FR) | 2014-07-03 | — | — | US | disclosed |
| US-8748651-B2 | Method for the synthesis of an omega-amino acid or ester starting from a monounsaturated fatty acid or ester | ARKEMA FRANCE (FR) | 2014-06-10 | — | — | US | disclosed |
| US-20110224454-A1 | METHOD FOR THE SYNTHESIS OF AN OMEGA-AMINO ACID OR ESTER STARTING FROM A MONOUNSATURATED FATTY ACID OR ESTER | ARKEMA FRANCE (FR) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224454-A1 | METHOD FOR THE SYNTHESIS OF AN OMEGA-AMINO ACID OR ESTER STARTING FROM A MONOUNSATURATED FATTY ACID OR ESTER | FASN, ELOVL6, ELOVL1 | BLM 4630/4885GABRR1 1889/4885GABRR2 1742/4885 |
| US-20140187808-A1 | METHOD FOR SYNTHESIZING AN OMEGA-AMINO ACID OR ESTER FROM A MONOUNSATURATED FATTY ACID OR ESTER | ALOX12, HAO2, FFAR2 | BLM 1085/4885GABRR1 1526/4885GABRR2 853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.